JW Pharmaceutical Q3 Operating Profit Falls 10.7% Year on Year
Bitget2026/11/04 08:01- JW Pharmaceutical’s third-quarter 2026 net profit fell 35.5% year over year to KRW 19.84 billion.
- Operating profit declined 10.7% year over year to KRW 29.15 billion.
- Revenue rose 6.3% from a year earlier to KRW 211.12 billion.
- For the first nine months of 2026, net profit increased 62.9% to KRW 75.36 billion.
- Nine-month revenue grew 10.2% to KRW 629.86 billion.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
SoftBank develops contingency plans for slowdown in US data center business, considers shifting to other countries
A new twist has emerged in the US AI data center investment boom. SoftBank is preparing for cooling US demand and a deteriorating political environment, and does not rule out shifting data center construction priorities to other countries. As cross-border computing power delivery capability improves and investment returns come under question, the logic behind AI infrastructure expansion is loosening, and over $3.5 trillion in infrastructure investment now faces potential impairment risks.
Quantumrail Cancels 10 Billion Won Convertible Bond Offering
Crypto prices
More
